Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The proposed study plans to examine the effect of flaxseed consumption, a phytoestrogen rich
food, compared to aromatase inhibitors as a complementary approach to treating estrogen
receptor positive breast cancer, as well as the effect of combined flaxseed and aromatase
inhibitor therapy on breast cancer treatment. Because of the increasing use of both
complementary and alternative approaches to treatment, and the use of aromatase inhibitors in
the treatment of breast cancer, the proposed study has potential to provide important
clinical information about the effect of foods high in phytoestrogens on a common endocrine
therapy used in breast cancer.
Phase:
N/A
Details
Lead Sponsor:
Roswell Park Cancer Institute
Collaborators:
AstraZeneca National Center for Complementary and Integrative Health (NCCIH)